Loading company…
Neukio Biotherapeutics develops allogeneic cell therapies for tumors.
Founded in 2021 and based in Shanghai, Neukio Biotherapeutics develops cell immunotherapies for tumors using modular and genetic technologies. Its pipeline includes natural killer cells and induced pluripotent stem cells. Founder Richard Liqun Wang previously served as CEO of Fosun Kite Biotech. The company has a 60,000-square-meter R&D and manufacturing center.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in